Answers are grounded in this paper and cite their sources.
Background Depressive symptoms are clinically important in palliative oncology, but interpretation is complicated by overlap between cancer-related somatic symptoms and depression-screening items. Saudi studies report psychological distress in advanced cancer, but PHQ-9 severity and symptom patterns in palliative oncology remain less characterized. Objective To characterize the frequency and severity of depressive symptoms using the Arabic PHQ-9, describe individual symptom patterns including thoughts of death or self-harm, and explore selected demographic and clinical characteristics associated with a PHQ-9 score ≥10. Methods This single-center cross-sectional study recruited adults with cancer receiving palliative care over 12 months. Data were collected through interviews and medical-record review. PHQ-9 severity categories and screening thresholds were summarized descriptively. Exploratory comparisons of PHQ-9 < 10 versus ≥10 used Fisher’s exact tests, unadjusted odds ratios (ORs) with 95% confidence intervals (CIs), and the Mann–Whitney U test for age. Individual cancer types and individual comorbidities were descriptive only. Results Of 150 patients approached, 90 consented, were assessed as eligible and participated (60.0%); eligibility was unknown for the 60 who declined. PHQ-9 scores were none/minimal in 43 (47.8%), mild in 22 (24.4%), moderate in 6 (6.7%), moderately severe in 9 (10.0%) and severe in 10 (11.1%). Scores ≥5, ≥10 and ≥15 occurred in 47 (52.2%; 95% CI 42.0–62.2%), 25 (27.8%; 19.6–37.8%) and 19 (21.1%; 14.0–30.6%), respectively. All 13 participants endorsing thoughts of death or self-harm (14.4%; 8.6–23.2%) received same-day psychiatric assessment. Exploratory associations were imprecise, with all categorical OR confidence intervals including 1. Conclusion Approximately half of participants reported at least mild depressive symptoms, while more than one-quarter met the conventional moderate-or-greater PHQ-9 screening threshold. Item-level assessment identified clinically important symptom burden, including thoughts of death or self-harm. These findings support careful early recognition and individualized assessment rather than diagnostic interpretation of screening scores.
No takes yet. Share an insight, caveat, or question.
Sharaf et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: